Application

MUCINEX FAST-MAX

RB Health (US) LLC

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97257726
Filing Date: 02/08/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97257726
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\972\577\97257726\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT MUCINEX FAST-MAX
COLOR MARK YES
COLOR(S) CLAIMED
(If applicable)
The color(s) red, blue, white and gray is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a red bar in the upper left corner of a white background. In the center of the top half of the field is the stylized word "MUCINEX" in blue on above the stylized words "FAST-MAX" in white and to the left of the "F" in FAST-MAX appear three triangles in white pointed to the left and to the right of the "X" in FAST-MAX appear two overlapping triangles in grey pointed to the right within a blue background, all of which is surrounded by a grey outline. In the center below the wording is gray arc that tapers at the edges. A red tablet design appears the bottom right corner surrounded by a white aura resting within a solid and dotted red field.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 573 x 900
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK RB Health (US) LLC
*MAILING ADDRESS 399 Interpace Parkway
*CITY Parsippany
*STATE
(Required for U.S. applicants)
New Jersey
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
07054
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE limited liability company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; decongestants; Pharmaceutical antitussive-cold preparations; Preparations for treating colds.
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 01/31/2016
       FIRST USE IN COMMERCE DATE At least as early as 01/31/2016
       SPECIMEN FILE NAME(S)
       ORIGINAL PDF FILE SPE0-50231115242-20220207 150844422525_._MUCINEX_FA ST-MAX___Design_specimen.pdf
       CONVERTED PDF FILE(S)
       (1 page)
\\TICRS\EXPORT18\IMAGEOUT 18\972\577\97257726\xml1\ APP0003.JPG
       SPECIMEN DESCRIPTION digital point of sale display
        WEBPAGE URL http://www.walmart.com/ip/Mucinex-Fast-Max-Maximum-Strength-Severe-Congestion-Cough-Multi-Symptom-Relief-Cough-Suppressant-Expectorant-Nasal-Decongestant-20-Caplets/32265572?athcpid=32265572&athpgid=AthenaItempage&athcgid=null&athznid=si&athieid=v0&athstid=CS004&athguid=RfXhV2TW7kHyPpyWfcVNhbx2HOi60Ci5Rrtg&athancid=null&athena=true
        WEBPAGE DATE OF ACCESS 02/07/2022
ATTORNEY INFORMATION
NAME Mark Lerner, Esq.
ATTORNEY DOCKET NUMBER S4888-00668
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME DUANE MORRIS LLP
STREET 230 Park Avenue, Suite 1130
CITY New York
STATE New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 10169
PHONE 212-404-8714
FAX 212 818-9606
EMAIL ADDRESS malerner@duanemorris.com
CORRESPONDENCE INFORMATION
NAME Mark Lerner, Esq.
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE malerner@duanemorris.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) trademarks@duanemorris.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /charlieeveritt/
SIGNATORY'S NAME Charlie Everitt
SIGNATORY'S POSITION Group Head of Brand Protection
SIGNATORY'S PHONE NUMBER 07408865200
DATE SIGNED 02/08/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97257726
Filing Date: 02/08/2022

To the Commissioner for Trademarks:

MARK: MUCINEX FAST-MAX (stylized and/or with design, see mark)
The literal element of the mark consists of MUCINEX FAST-MAX. The color(s) red, blue, white and gray is/are claimed as a feature of the mark. The mark consists of a red bar in the upper left corner of a white background. In the center of the top half of the field is the stylized word "MUCINEX" in blue on above the stylized words "FAST-MAX" in white and to the left of the "F" in FAST-MAX appear three triangles in white pointed to the left and to the right of the "X" in FAST-MAX appear two overlapping triangles in grey pointed to the right within a blue background, all of which is surrounded by a grey outline. In the center below the wording is gray arc that tapers at the edges. A red tablet design appears the bottom right corner surrounded by a white aura resting within a solid and dotted red field.
The applicant, RB Health (US) LLC, a limited liability company legally organized under the laws of Delaware, having an address of
      399 Interpace Parkway
      Parsippany, New Jersey 07054
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations and substances for the treatment of coughs and the symptoms of colds and influenza; preparations for the treatment of respiratory and pulmonary conditions; expectorants; decongestants; Pharmaceutical antitussive-cold preparations; Preparations for treating colds.

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 01/31/2016, and first used in commerce at least as early as 01/31/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) digital point of sale display.

Original PDF file:
SPE0-50231115242-20220207 150844422525_._MUCINEX_FA ST-MAX___Design_specimen.pdf
Converted PDF file(s) (1 page)
Specimen File1
Webpage URL: http://www.walmart.com/ip/Mucinex-Fast-Max-Maximum-Strength-Severe-Congestion-Cough-Multi-Symptom-Relief-Cough-Suppressant-Expectorant-Nasal-Decongestant-20-Caplets/32265572?athcpid=32265572&athpgid=AthenaItempage&athcgid=null&athznid=si&athieid=v0&athstid=CS004&athguid=RfXhV2TW7kHyPpyWfcVNhbx2HOi60Ci5Rrtg&athancid=null&athena=true
Webpage Date of Access: 02/07/2022




The owner's/holder's proposed attorney information: Mark Lerner, Esq.. Mark Lerner, Esq. of DUANE MORRIS LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
      230 Park Avenue, Suite 1130
      New York, New York 10169
      United States
      212-404-8714(phone)
      212 818-9606(fax)
      malerner@duanemorris.com
The docket/reference number is S4888-00668.
Mark Lerner, Esq. submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Mark Lerner, Esq.
       PRIMARY EMAIL FOR CORRESPONDENCE: malerner@duanemorris.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): trademarks@duanemorris.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /charlieeveritt/   Date: 02/08/2022
Signatory's Name: Charlie Everitt
Signatory's Position: Group Head of Brand Protection
Signatory's Phone Number: 07408865200
Signature method: Sent to third party for signature
Payment Sale Number: 97257726
Payment Accounting Date: 02/08/2022

Serial Number: 97257726
Internet Transmission Date: Tue Feb 08 13:58:21 ET 2022
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202202081358219
03077-97257726-810a1fa4be72daa981eab6357
b3c9d884a196a6d5446f850a79db311eaecbc21e
-DA-58212352-20220207164219682317

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed